|
|
News for:
|
|
For this drug, our server compiled this detailed Chemical Profile.
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
|
Click the Chemical Profile link above for detailed information.
Visit Betterchem's Drug Index for
- Exclusivity
Patents and market exclusivity
- Drug Information
Prescribing and other
information
- DMFs
Type 2 drug master files
- Databases
Free access to database search
- 21 CFR
FDA regulations for this drug
- Federal Register
FR search results for this drug
- Drug Recalls
For Rx's using this API
|
|
|
| |
FDA Approval Activities for this Drug
ELOCON (mometasone furoate) Cream, 0.1%, Schering NDA 19-625/S-012 & S-013 7/17/02 7/24/02 7/19/02
ELOCON (mometasone furoate) Lotion, 0.1%, Schering NDA 19-796/S-08 & S-015 7/17/02 7/24/02 7/19/02
ELOCON (mometasone furoate) Ointment, 0.1%, Schering NDA 19-543/S-014 12/15/02 1/23/03 12/16/02
ELOCON (mometasone furoate) Ointment, 0.1%, Schering NDA 19-543/S-011 & S-013 Mometasone Furoate Cream USP, 0.1%, Altana ANDA 76-171 7/10/02
Mometasone Furoate Ointment USP, 0.1%, Clay-Park Labs, ANDA 76-067 3/18/02 4/10/03
Mometasone Furoate Ointment USP, 0.1%, Clay-Park Labs, ANDA 76-067 2/1/02
Mometasone Furoate Topical Solution USP, 0.1%, Altana ANDA 75-919 Nasonex (Mometasone Furoate Monohydrate) Aqueous Nasal Spray, Schering Corp. NDA 20-762/S-014 3/3/03 3/10/03
Nasonex Nasal Spray, 50 mcg., Schering Corp. NDA 20-762/S-001 11/19/98 1/12/99 5/25/01
Nasonex Indication: Prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and the treatment of the nasal symptoms of perennial allergic rhinitis, in adults and children 12 years of age and older. Mometasone Furoate Ointment USP, Atrix Mometasone Furoate Topical Solution, Atrix Laboratories, Nasonex (Mometasone Furoate Monohydrate) Aqueous Nasal Spray, Schering Corp. Mometasone Furoate Cream USP, Atrix Laboratories, Inc., Nasonex (mometasone furoate monohydrate) Aqueous Nasal Spray, Schering Corp., Formulation Revision | Mometasone Furoate Cream, Taro Pharmaceuticals, Tentative Approval |Mometasone Furoate Ointment, Taro Pharmaceuticals, Approval |
Mometasone Furoate Topical Solution, Taro Pharmaceuticals, Tentative Approval | Mometasone Furoate Ointment, Altana Inc., Approval 077061 | Asmanex Twisthaler (mometasone furoate) inhalation powder, Schering Corp., Approval | Mometasone Furate Topical Solution, Agis, Approval | Mometasone Furoate Cream, Altana Inc., Approval | ELOCON (mometasone furoate) Lotion, Schering Corp., Labeling Revision | Mometasone Furoate Cream, G & W Labs, Tentative Approval | Mometasone Furoate Lotion, G & W Labs, Tentative Approval| Mometasone Furoate Topical Solution USP, Taro Pharma, Approval | Mometasone Furoate Cream, G&W Labs, Approval | Mometasone Furoate Ointment, G & W Labs, Approval
Visit Betterchem's Drug Index for FDA's latest approval information.
|
|